BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2981223)

  • 21. Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity.
    Konopka JB; Davis RL; Watanabe SM; Ponticelli AS; Schiff-Maker L; Rosenberg N; Witte ON
    J Virol; 1984 Jul; 51(1):223-32. PubMed ID: 6610061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts.
    Saggioro D; Ferracini R; Di Renzo MF; Naldini L; Chieco-Bianchi L; Comoglio PM
    Int J Cancer; 1986 Apr; 37(4):623-8. PubMed ID: 2420727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Abelson murine leukemia virus oncogene.
    Goff SP
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):403-12. PubMed ID: 2991935
    [No Abstract]   [Full Text] [Related]  

  • 24. Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality.
    Watanabe SM; Witte ON
    J Virol; 1983 Mar; 45(3):1028-36. PubMed ID: 6300444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two families of abl-related transcripts in human haematopoietic cells differing in their homology to v-abl.
    Savin KW; Adams FC; Devereux LM; Jose DG; de Kretser TA
    Mol Biol Med; 1984 Dec; 2(6):397-409. PubMed ID: 6085879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
    Prywes R; Foulkes JG; Rosenberg N; Baltimore D
    Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
    Hines DL
    Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abelson murine leukemia virus: structural requirements for transforming gene function.
    Srinivasan A; Dunn CY; Yuasa Y; Devare SG; Reddy EP; Aaronson SA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5508-12. PubMed ID: 6291048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human v-abl cellular homologue.
    Heisterkamp N; Groffen J; Stephenson JR
    J Mol Appl Genet; 1983; 2(1):57-68. PubMed ID: 6302194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the feline c-abl proto-oncogene.
    Schalken JA; van den Ouweland AM; Bloemers HP; van de Ven WJ
    Biochim Biophys Acta; 1985 Feb; 824(2):104-12. PubMed ID: 2982404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
    Chen YY; Wang LC; Huang MS; Rosenberg N
    Genes Dev; 1994 Mar; 8(6):688-97. PubMed ID: 7926759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
    Chen YY; Rosenberg N
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From c-abl to v-abl.
    Wang JY
    Nature; 1983 Aug 4-10; 304(5925):400. PubMed ID: 6308459
    [No Abstract]   [Full Text] [Related]  

  • 35. Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products.
    Groffen J; Heisterkamp N; Reynolds FH; Stephenson JR
    Nature; 1983 Jul 14-20; 304(5922):167-9. PubMed ID: 6191223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence.
    Wang JY; Baltimore D
    Mol Cell Biol; 1983 May; 3(5):773-9. PubMed ID: 6306446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mouse c-abl locus: molecular cloning and characterization.
    Wang JY; Ledley F; Goff S; Lee R; Groner Y; Baltimore D
    Cell; 1984 Feb; 36(2):349-56. PubMed ID: 6319018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 1.
    Kruse CH; Holden KG; Pritchard ML; Feild JA; Rieman DJ; Greig RG; Poste G
    J Med Chem; 1988 Sep; 31(9):1762-7. PubMed ID: 2970550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line.
    Mathey-Prevot B; Nabel G; Palacios R; Baltimore D
    Mol Cell Biol; 1986 Nov; 6(11):4133-5. PubMed ID: 3025637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the Abelson murine leukemia virus-encoded tyrosine-specific protein kinase.
    Wang JY; Baltimore D
    Methods Enzymol; 1983; 99():373-8. PubMed ID: 6196601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.